Will Immuron stock go up?

According to Danelfin AI, Immuron has today an AI Score of 3/10 (Sell rating), because its probability of beating the market in 3 months (47.15%) is -3.67% vs. the average probability (50.82%) of all US-listed stocks.

What is the target price for Immuron stock?

The Immuron target price is $1.12 (1Y), according to the average price target offered by analysts.

Is it a good time to buy, sell, or hold Immuron stock right now?

Immuron has today a Sell rating (AI Score 3/10), according to Danelfin AI. Its probability of beating the market in 3 months (47.15%) is -3.67% vs. the average probability (50.82%) of all US-listed stocks, based on our AI-powered analysis. You can find more details on whether Immuron stock is a good buy .

Is Immuron undervalued right now?

Based on analysts, the average price target downside for Immuron is 0.00% (1Y). According to Danelfin AI, Immuron has today an AI Score of 3/10 (Sell Rating).

What was the price range of Immuron stock over the past 12 months?

The Immuron stock price range over the past 12 months has been $0.7 - $2.35.

What is going on with Immuron stock in the last 3 months?

The Immuron stock performance in the last quarter has been +38.78%.

Does Immuron offer dividend payments?

No, Immuron does not currently pay dividends.

What is the current market capitalization of Immuron?

Immuron's market cap is $8.88M, as of 2026-07-03 08:00.

Immuron Ltd (IMRN) AI Stock Analysis

Advanced Chart

Custom range

Jul 3, 2025

→

Jul 3, 2026

Custom range

Jul 3, 2025

→

Jul 3, 2026

IMRN AI-Powered Stock Analysis

AI Score Explanation

Generating AI Score explanation

We're getting the explanation ready so you can easily understand what's behind the AI Score. This may take a few seconds.

AI Score Explanation

Generating AI Score explanation

We're getting the explanation ready so you can easily understand what's behind the AI Score. This may take a few seconds.

Momentum+42.83%
Direction and strength of recent price movements

Valuation-26.35%
How the stock is priced relative to its fundamentals
Sentiment-12.90%
How analysts and the market view the stock
Volatility-7.25%
How much the stock price tends to fluctuate

IMRN probability advantage of beating the market (3M):

-3.67%

Technical

Immuron (IMRN) has a Technical Score of 5/10 because, according to only technical analysis, it has a probability advantage of -0.80% of beating the market (S&P500) in the next 3 months. This advantage is calculated as the difference between the average probability of any US-listed stock (50.73%) and the probability of IMRN (49.93%) of overperforming the market in the next 3 months, as determined by Danelfin AI’s technical analysis.

Average probability of any US-listed stock of beating the market (3M)50.73%
IMRN probability advantage of beating the market (only technical, 3M)-0.80%
IMRN probability of beating the market (3M)49.93%

IMRN probability advantage of beating the market (only technical, 3M): -0.80%

The AI-powered technical analysis of Immuron (IMRN) is only based on the 30 technical features that had the greatest impact on stock performance during the last 12 months (alpha signals). These alpha signals explain the probability advantage of IMRN:

Type	Alpha Signal	Probability Advantage Impact (3M)
Technical	Upgrade to Pro to unlock	-0.42%
Technical	Upgrade to Pro to unlock	-0.41%
Technical	Upgrade to Pro to unlock	+0.40%
Technical	Upgrade to Pro to unlock	+0.37%
Technical	Upgrade to Pro to unlock	+0.36%
Technical	Upgrade to Pro to unlock	-0.29%
Technical	Upgrade to Pro to unlock	-0.27%
Technical	Upgrade to Pro to unlock	+0.26%
Technical	Upgrade to Pro to unlock	-0.24%
Technical	Upgrade to Pro to unlock	-0.22%
Technical	Upgrade to Pro to unlock	+0.21%
Technical	Upgrade to Pro to unlock	-0.20%
Technical	Upgrade to Pro to unlock	-0.19%
Technical	Upgrade to Pro to unlock	-0.19%
Technical	Upgrade to Pro to unlock	-0.18%

Rest of Alpha Signals: +0.23%

IMRN probability advantage of beating the market (only technical, 3M)Total:-0.80%
IMRN Technical Score

Significant changes Vs previous day

IMRN Short Trading Parameters

These suggested trading parameters for a 3-month horizon help improve risk management and decision-making.

Entry:$1.12
Horizon: 3 months
Stop Loss:$XXXXXPro (XXXXXPro)
Take Profit:$XXXXXPro (XXXXX
Pro
)

IMRN Proven Sell Signal & Price Forecast

This is the price chart for IMRN from January 2, 2026 until today. The chart indicates, in red, the 17 days when the stock received a Sell/Strong Sell rating (sell signals, AI Score 1 to 3).

Forecast: In the section below, the central dotted line represents the most expected path, while the shaded area indicates the anticipated price range. This is based on previous Sell signals with a 90% confidence level.

Full Track Record

Unlock AI-powered forecast

Closing price (USD)
Sell signals

Forecast:

1 Month
3 Months
6 Months
1 Year

IMRN Average Past Performance & Loss Rate

Three months after its 651 Sell signals since July 2026, IMRN had an average performance of xxxxxx and a xxxxxx Loss rate (negative performance).

651 Past IMRN Sell Signals	1 Month Later	3 Months Later	6 Months Later	1 Year Later
Average Performance				+18.24%
Average Alpha				+2.50%
Loss Rate (% Negative Perf.)				55.35%
% Negative Alpha				65.57%

IMRN Frequently Asked Questions

Will Immuron stock go up?
According to Danelfin AI, Immuron has today an AI Score of 3/10 (Sell rating), because its probability of beating the market in 3 months (47.15%) is -3.67% vs. the average probability (50.82%) of all US-listed stocks.
What is the target price for Immuron stock?
Is it a good time to buy, sell, or hold Immuron stock right now?
Is Immuron undervalued right now?
What was the price range of Immuron stock over the past 12 months?
What is going on with Immuron stock in the last 3 months?
Does Immuron offer dividend payments?
What is the current market capitalization of Immuron?

Immuron Ltd Company Profile

Immuron Limited, originating from Australia and operating across Canada, Israel, the United States and beyond, is a biopharmaceutical corporation dedicated to the exploration, evolution, and distribution of polyclonal antibodies. With an operational focus split evenly between Research & Development and Hyperimmune Products divisions, the company prides itself on its innovative product offerings.

Among its standout offerings is Travelan, a commercially available medicine that actively serves to reduce travelers' diarrhea risk while also diminishing minor gastrointestinal disorders. As an added advantage, this product doubles as a dietary supplement for digestive wellness and protection of your gastrointestinal tract. Another key product in its repertoire is Protectyn; poised as an immune supplement it helps sustain healthy liver functions and digestive efficiency.

The company's ambition doesn't stop in this arena though. Currently under development is Travelan (IMM-124E) with a primary objective of slashing the odds of contracting travelers' diarrhea within U.S contexts and Travelers' Diarrhea itself. Immuron Limited has further endeavored into research for IMM-529 with plans to treat patients affected by persistent clostridium difficile infection.

Collaborative efforts have been made with the Naval Medical Research Center; jointly planning to devise and examine therapeutics aimed at Campylobacter infections along with enterotoxigenic Escherichia coli infections. Notably, they also have linkage with the Walter Reed Army Institute of Research with whom they aspire to deliver an orally consumable treatment for shigellosis.

Founded in 1994, Immuron Limited continues to advance its mission from their base located in Carlton, Australia.

Sector:
Country:Australia
Industry:
Address:62 Lygon Street, Level 3, Melbourne
Employees:7

Pros

Proprietary oral antibody technology platform

Addressing unmet medical needs in gut health

Non-antibiotic mechanism of action for infectious diseases

Potential for pipeline expansion into new indications

Established over-the-counter product distribution network

Cons

High capital intensity for clinical development programs

Extensive regulatory approval pathways for novel therapies

Clinical trial failure risk for product candidates

Competition from established pharmaceutical and biotech firms

Reliance on bovine colostrum supply chain for manufacturing

Company	AI Score	Compare
IMNNImunon Inc
IBRXImmunitybio Inc
IMCRImmunocore Holdings PLC
IMUXImmunic Inc
IMVTImmunovant Inc

Company	AI Score	Compare
IMNNImunon Inc
IBRXImmunitybio Inc
IMCRImmunocore Holdings PLC
IMUXImmunic Inc
IMVTImmunovant Inc

IMRN Stock AI Analysis

Immuron Ltd

IMRN Stock AI Analysis

Immuron Ltd

IMRN AI-Powered Stock Analysis

AI Score Explanation

Generating AI Score explanation

AI Score Explanation

Generating AI Score explanation

AI Score Alpha Factors

Alpha Signals: What Drives the AI Score

IMRN probability advantage of beating the market (only technical, 3M): -0.80%

IMRN Short Trading Parameters

IMRN Proven Sell Signal & Price Forecast

IMRN Average Past Performance & Loss Rate

IMRN Frequently Asked Questions

Will Immuron stock go up?

What is the target price for Immuron stock?

Is it a good time to buy, sell, or hold Immuron stock right now?

Is Immuron undervalued right now?

What was the price range of Immuron stock over the past 12 months?

What is going on with Immuron stock in the last 3 months?

Does Immuron offer dividend payments?

What is the current market capitalization of Immuron?

Immuron Ltd Company Profile

Pros

Cons

Pros

Cons

IMRN Company Profile Summary

IMRN Related Investment Themes

IMRN Related Stocks

IMRN Top 10 Industry Stocks

Biotechnology

IMRN Top 10 Sector Stocks

Health Care

IMRN Stock AI Analysis

Immuron Ltd

ASX - ALL MARKETS

Will Immuron stock go up?

What is the target price for Immuron stock?

Is it a good time to buy, sell, or hold Immuron stock right now?

Is Immuron undervalued right now?

What was the price range of Immuron stock over the past 12 months?

What is going on with Immuron stock in the last 3 months?

Does Immuron offer dividend payments?

What is the current market capitalization of Immuron?

ASX - ALL MARKETS

Pros

Cons

IMRN Proven Sell Signal & Price Forecast

AI Score Explanation

Generating AI Score explanation